EQUITY PURCHASE AGREEMENT BY AND BETWEEN ENTEST BIOMEDICAL, INC. AND SOUTHRIDGE PARTNERS II, LP Dated June 1, 2012Equity Purchase Agreement • June 4th, 2012 • Entest Biomedical, Inc. • Agricultural services • New York
THIS EQUITY PURCHASE AGREEMENT entered into as of the 1st day of June, 2012 (this "AGREEMENT"), by and between SOUTHRIDGE PARTNERS II, LP, Delaware limited partnership ("INVESTOR"), and ENTEST BIOMEDICAL, INC., a Nevada corporation (the "COMPANY").
ESCROW AGREEMENTEscrow Agreement • November 4th, 2008 • JB Clothing Corp • Nevada
AGREEMENT made as of the 22nd day of October 2007 by and between JB Clothing Corporation (“Issuer”), and the Law Offices of Joseph L. Pittera, 2214 Torrance Boulevard, Suite 101, Torrance, California 90501 (the “Escrow Agent”)
SECURITIES TRANSFER AGREEMENTSecurities Transfer Agreement • July 16th, 2012 • Entest Biomedical, Inc. • Agricultural services • New York
SECURITIES TRANSFER AGREEMENT (the “Agreement”), dated as of June 15, 2012, by and between Sherman Family Trust (“Seller”), and SGI Group LLC (“Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 2nd, 2018 • Entest Group, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and Hall Family Trust dated 7/21/2003 (“Purchaser”) a person whose address is 5019 Tierra Del Oro Carlsbad CA.
ContractAcquisition Agreement • January 11th, 2011 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear
On January 4, 2011, 2010 Entest BioMedical, Inc. (“Entest CA”), a California corporation and a wholly owned subsidiary of Entest BioMedical, Inc., a Nevada corporation (the “Company”) acquired from Pet Pointers, Inc., a California corporation doing business as McDonald Animal Hospital (“Seller”), and Dr. Gregory McDonald DVM (“McDonald”) all the goodwill from McDonald and assets of Seller except cash and accounts receivables used in connection with the operation of a veterinary medical clinic located at 225 S. Milpas Street, Santa Barbara, CA 93103 (the "Business").
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLYConsulting Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Agreement made on August 7, 2017 ("Execution Date") by and between Thomas Donnelly ("Consultant"), a natural person whose address is at 44 Rue Bourgelat, 94700 Maisons-Alfort, FRANCE and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
ContractConsulting Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Agreement made on March 20, 2017 (“Execution Date”) by and between Linda Black (“Consultant”), a natural person whose address is ___________and Entest BioMedical Inc.
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Todd S. CavenEmployment Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 21, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").
ContractBusiness Advisory Board Services Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
This Business Advisory Board Services Agreement (the “Agreement”), dated June 23, 2017, is entered into between Zander Therapeutics, Inc., a Nevada corporation (“the Company), and Brian Devine, an individual with a principal place of residence California(“Candidate”).
Investor Relations Consulting Agreement Between Entest BioMedical Inc. And Synergy Business Consultants LLCInvestor Relations Consulting Agreement • June 22nd, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
This document acts forth the agreement Entest BioMedical Inc. (“the Company”) and Synergy Business Consultants LLC concerning Investor Relation and Financial Public Relation services rendered to the Company from April 24, 2017 and continuing through May 24, 2017. (1 month).
AMENDMENT TO SUBLEASE AGREEMENT (“AGREEMENT”) ENTERED INTO OCTOBER 1, 2014 BY AND BETWEEN ENTEST BIOMEDICAL, INC. ( “SUBLESSOR”) AND REGEN BIOPHARMA,INC (“SUBTENANT”)Sublease Agreement • April 10th, 2015 • Entest Biomedical, Inc. • Pharmaceutical preparations
SUBLEASE AGREEMENTSublease Agreement • January 13th, 2015 • Entest Biomedical, Inc. • Pharmaceutical preparations
This is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Harry M. Lander, Ph.D., M.B.A.Employment Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 5, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the ''Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the (“Company'') whose address is
Contract10% Convertible Note • June 12th, 2012 • Entest Biomedical, Inc. • Agricultural services • New York
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM OR IN A TRANSACTION NOT SUBJECT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO REGISTRATION UNDER THE ACT.
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated September 12, 2017License Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
On April 7, 2010 The Entest Biomedical, inc. (“Company”) and Ms. Tammy Reynolds have agreed that Ms. Reynolds shall receiveEmployment Agreement • June 12th, 2012 • Entest Biomedical, Inc. • Agricultural services
EMPLOYMENT AGREEMENT BETWEEN ENTEST BIOMEDICAL, INC. AND DR. GREGORY MCDONALD, DVMEmployment Agreement • December 27th, 2010 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of December 31, 2010 is entered into between Entest BioMedical, Inc., a California corporation, (the "Company") and Dr. Gregory McDonald ("Employee").
ContractCollaboration Agreement • August 25th, 2009 • JB Clothing Corp • Women's, misses', and juniors outerwear
AGREEMENT made this 18th day of August, 2009, by and between Therinject LLC, whose principal place of business is 10439 Roselle St Ste E hereinafter referred to as "Therinject", Steven Josephs, whose address is 1129 Rising Hill Way, Escondido, CA 92029 hereinafter referred to as “Josephs” and Bio-Matrix Scientific Group, Inc., whose principal place of business is 8885 Rehco Road, San Diego, California 92121, hereinafter referred to as "Company". Collectively, the Company, Therinject and Josephs may be referred to as the “Parties” or, singularly as “Party”
STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 22nd, 2009 • JB Clothing Corp • Women's, misses', and juniors outerwear • California
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into and is effective on this 16th day of June 2009 by and between JB Clothing Corporation, a Nevada corporation with principal address at 47 Fountainhead Circle, Henderson, Nevada 89052 (the “Buyer”), and Bio-Matrix Scientific Group, Inc., a Delaware corporation with principal address at 8885 Rehco Road, San Diego, California 92121 (the “Seller”). As used in this Agreement, the term, “Parties” shall refer to the Buyer and the Seller jointly.
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated June 15, 2016License Agreement • November 23rd, 2016 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • December 27th, 2010 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear
This Asset Purchase Agreement ("AGREEMENT") is made as of December 17, 2010 by and among ENTEST BIOMEDICAL, INC., a California corporation (“Buyer”) which is wholly owned by ENTEST BIOMEDICAL INC., A Nevada corporation publicly traded on the OTC Bulletin Board under the symbol ENTB, PET POINTERS, INC., a California corporation ("Seller") doing business as McDonald Animal Hospital and DR. GREGORY MCDONALD, the sole shareholder, officer and director of the Seller (“Dr. Gregory McDonald” or “McDonald”).
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. DATED SEPTEMBER 28, 2015License Agreement • October 2nd, 2015 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
WHEREAS on June 23, 2015 Regen Biopharma, Inc. (“Regen”) entered into an agreement (“Agreement”) with Zander Therapeutics, Inc. (“Zander”) whereby Regen granted to Zander an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by Regen (“License IP”) for non-human veterinary therapeutic use for a term of fifteen years.
Agreement by and between David R. Koos and Entest BioMedical Inc. (“Agreement”)Employment Agreement • November 17th, 2009 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear • California
WHEREAS, Entest BioMedical, Inc. (“ENTB”), a Nevada Corporation, wishes to secure the services of David R. Koos (“Koos”) as ENTB’s President and Chief Executive Officer (“CEO”)
ContractDebt Satisfaction Agreement • May 31st, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations
DEBT SATISFACTION AGREEMENT (“AGREEMENT”) ENTERED INTO BY AND BETWEEN ENTEST BIOMEDICAL, INC. (“DEBTOR”) AND REGEN BIOPHARMA, INC. (“CREDITOR”) DATED MAY 25, 2017.
Escrow AgreementEscrow Agreement • February 15th, 2011 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear • California
This Escrow Agreement (the "Escrow Agreement") is entered into as of February 14, 2011 by and between Herman H. Pettegrove (the "Escrow Agent"), Entest BioMedical Inc. (“Purchaser”), Noah’s Ark Starr Animal Hospital, Inc. and Barbara Starr, DVM (collectively the “Seller”), herein collectively referred to herein as the “Parties” (“Parties”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • July 10th, 2009 • JB Clothing Corp • Women's, misses', and juniors outerwear • California
This Exclusive License Agreement and the attached Appendix A (collectively, the “Agreement”) is made and is effective this 26th day of September 2008 (the "Effective Date") between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ("The Regents"), a California corporation having its corporate offices located at 1111 Franklin Street, Oakland, California 94607-5200, acting through The Office of Intellectual Property Administration of the University of California, Los Angeles, located at 11000 Kinross Avenue, Suite 200, Los Angeles, CA 90095-1406 and Entest BioMedical Inc. ("Licensee"), a corporation having a principal place of business at 1010 University Avenue #40, San Diego, CA 92103.
Escrow AgreementEscrow Agreement • October 28th, 2010 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear • California
This Escrow Agreement (the "Escrow Agreement") is entered into as of October 26, 2010, by and between Herman H. Pettegrove (the "Escrow Agent"), Entest BioMedical Inc. (“Purchaser”) and Greg McDonald, DVM (the “Seller”), herein collectively referred to herein as the “Parties” (“Parties”).
ContractDebt Satisfaction Agreement • May 31st, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations
DEBT SATISFACTION AGREEMENT (“AGREEMENT”) ENTERED INTO BY AND BETWEEN ENTEST BIOMEDICAL, INC. (“DEBTOR”) AND BOSTONIA PARTNERS INC. (“CREDITOR”) DATED MAY 25, 2017.
ContractDebt Satisfaction Agreement • May 31st, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations
DEBT SATISFACTION AGREEMENT (“AGREEMENT”) ENTERED INTO BY AND BETWEEN ENTEST BIOMEDICAL, INC. (“DEBTOR”) AND BIOTECHNOLOGY PARTNERS BUSINESS TRUST (“CREDITOR”) DATED MAY 25, 2017.
SETTLEMENT AGREEMENTSettlement Agreement • December 12th, 2012 • Entest Biomedical, Inc. • Agricultural services • California
This Settlement Agreement ("Agreement") is entered into by and between Gregory McDonald ("McDonald"), Pet Pointer, Inc. ("Pet Pointer"), Entest BioMedical, Inc. a California corporation ("Entest California"), Entest BioMedical, Inc., a Nevada corporation ("Entest Nevada"), and David Koos ("Koos"). McDonald and Pet Pointer are collectively referred to as Plaintiffs. Entest California, Entest Nevada, and Koos are collectively referred to as Defendants. Plaintiffs and Defendants are collectively referred to as the Parties.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 20th, 2018 • Entest Group, Inc. • Pharmaceutical preparations • New York
This STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of November 15, 2018, by and between Peiwen Yu, with its offices located at No. 911 Bao'an Book City XInqiao Street Central Road, Bao'an District, Shenzhen City, China (the “Purchaser”), and David Koos, Regen BioPharma Inc., Bostonia Partners Inc., Sherman Family Trust, Dunhill Ross Partners Inc. and Bio-Technology Partners Business Trust (each, a “Seller” and collectively, the “Sellers”) with David Koos as Sellers Representative, whose office is located at 4700 Spring Street, Suite 304, La Mesa, California, 91942, a controlling shareholder as well as Chief Executive Officer, Chief Financial Officer and the sole director of Entest Group, Inc., a Nevada corporation (the “Company”).
The obligation of Entest BioMedical, Inc. to be bound by the terms and conditions of this Veterinary Hospital Director and Administrator Employment Agreement is contingent upon the successful acquisition of 100% of the assets of Rainbow Veterinary...Veterinary Hospital Director and Administrator Employment Agreement • August 11th, 2011 • Entest Biomedical, Inc. • Agricultural services
This agreement is made on July 20th between Entest BioMedical Inc. (herein referred to as the Company and / or the Hospital) and Dr. Tim Metzger (hereinafter called the director/administrator).
July 19, 2011 Dr. Kathy Snell Dr. Ron Titterington Titterington Veterinary Services, Inc. Dba Emerald Valley Pet Medical Center Re: Non-Binding Letter of Intent Dear Dr. Snell and Dr. Titterington:Non-Binding Letter of Intent • July 19th, 2011 • Entest Biomedical, Inc. • Agricultural services • California
This Letter of Intent (“LOI”) constitutes a proposal from Entest BioMedical Inc. (hereinafter, “Buyer”) to Titterington Veterinary Services, Inc. (“Seller”) to buy all the assets owned by Seller and utilized by the Seller in connection with the operation and management of its business located at 3880 West 11th Avenue, Eugene, Oregon (the “Business”) with the exception of any cash accounts (“Business Assets”). Buyer and Seller may be referred to individually as “Party” and collectively as “Parties”. The contemplated transaction shall be referred to as “the Transaction”
April 5, 2010 Attention: Dr. Neil Riordan Dr. Thomas Ichim Medistem, Inc. Re: Acquisition of Share Equity of Medistem, Inc, a Nevada corporation Gentlemen:Acquisition Agreement • April 13th, 2010 • Entest Biomedical, Inc. • Women's, misses', and juniors outerwear
This letter confirms our understanding of the mutual present intentions of Entest BioMedical, Inc. (the "Purchaser"), Medistem, Inc. (“Company”) and Dr. Neil Riordan, AIDAN Research and Consulting LLC and Aidan Foundation (collectively the "Seller") with respect to the principal terms and conditions under which the Purchaser will acquire approximately 61.4495% of the outstanding capital stock of the Company. Seller represents there are 4,977,976 common shares outstanding and no other classes of stock outstanding. Such transaction is hereinafter referred to as the "Acquisition."
